HUSSAIN IQBAL J (CIK 1862050) reported 37 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-24). Recent activity: Sell CNTA (117,645 shares), Sell CNTA (5,500 shares), Sell CNTA (1,010 shares), Sell CNTA (7,780 shares), Sell CNTA (38,951 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-24 | Centessa Pharmaceuticals plc (CNTA) | Chief Legal Officer | Sell | 117,645 | $0 |
| 2026-06-24 | Centessa Pharmaceuticals plc (CNTA) | Chief Legal Officer | Sell | 5,500 | $0 |
| 2026-02-03 | Centessa Pharmaceuticals plc (CNTA) | Chief Legal Officer | Sell | 1,010 | $25,260 |
| 2026-02-03 | Centessa Pharmaceuticals plc (CNTA) | Chief Legal Officer | Sell | 7,780 | $191,155 |
| 2026-02-03 | Centessa Pharmaceuticals plc (CNTA) | Chief Legal Officer | Sell | 38,951 | $979,618 |
| 2026-02-03 | Centessa Pharmaceuticals plc (CNTA) | Chief Legal Officer | Buy | 40,000 | $0 |
| 2026-02-03 | Centessa Pharmaceuticals plc (CNTA) | Chief Legal Officer | Buy | 20,000 | $0 |
| 2025-11-18 | Centessa Pharmaceuticals plc (CNTA) | General Counsel | Buy | 6,000 | $35,040 |
| 2025-11-18 | Centessa Pharmaceuticals plc (CNTA) | General Counsel | Sell | 6,000 | $165,840 |
| 2025-10-16 | Centessa Pharmaceuticals plc (CNTA) | General Counsel | Buy | 6,000 | $35,040 |
| 2025-10-16 | Centessa Pharmaceuticals plc (CNTA) | General Counsel | Sell | 6,000 | $134,460 |
| 2025-09-15 | Centessa Pharmaceuticals plc (CNTA) | General Counsel | Sell | 6,000 | $131,100 |
| 2025-09-15 | Centessa Pharmaceuticals plc (CNTA) | General Counsel | Buy | 6,000 | $35,040 |
| 2025-09-11 | Centessa Pharmaceuticals plc (CNTA) | General Counsel | Buy | 20,000 | $116,800 |
| 2025-09-11 | Centessa Pharmaceuticals plc (CNTA) | General Counsel | Sell | 20,000 | $400,200 |
| 2025-09-11 | Centessa Pharmaceuticals plc (CNTA) | General Counsel | Buy | 20,000 | $116,800 |
| 2025-09-11 | Centessa Pharmaceuticals plc (CNTA) | General Counsel | Sell | 20,000 | $440,000 |
| 2025-08-15 | Centessa Pharmaceuticals plc (CNTA) | General Counsel | Buy | 6,000 | $35,040 |
| 2025-08-15 | Centessa Pharmaceuticals plc (CNTA) | General Counsel | Sell | 6,000 | $103,380 |
| 2025-07-17 | Centessa Pharmaceuticals plc (CNTA) | General Counsel | Buy | 6,000 | $35,040 |
| 2025-07-17 | Centessa Pharmaceuticals plc (CNTA) | General Counsel | Sell | 6,000 | $89,580 |
| 2025-06-25 | Centessa Pharmaceuticals plc (CNTA) | General Counsel | Buy | 12,000 | $70,080 |
| 2025-06-25 | Centessa Pharmaceuticals plc (CNTA) | General Counsel | Sell | 12,000 | $168,240 |
| 2025-05-02 | Centessa Pharmaceuticals plc (CNTA) | General Counsel | Buy | 311 | $1,816 |
| 2025-05-02 | Centessa Pharmaceuticals plc (CNTA) | General Counsel | Sell | 311 | $4,354 |
Source: SEC Form 4 filings · as of 2026-06-24